TVTX
NASDAQ · Biotechnology
Travere Therapeutics Inc
$48.97
-3.45 (-6.58%)
Performance
1D
—
1W
-2.82%
1M
-8.36%
3M
-19.58%
6M
+12.55%
1Y
+47.06%
YTD
+23.91%
Open$52.16
Previous Close$52.42
Day High$52.43
Day Low$48.59
52W High$68.73
52W Low$22.59
Volume—
Avg Volume2.14M
Market Cap4.75B
P/E Ratio—
EPS$-0.50
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$58.12
Below
SMA 200
$46.95
Above
RSI (14)
48.7
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
21 analysts
Price Target
-24.1% upside
Current
$48.97
$48.97
Target
$37.15
$37.15
$26.93
$37.15 avg
$48.45
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 513.86M | 388.47M | 873.79M |
| Net Income | -26,754,790 | -18,203,289 | 83.63M |
| Profit Margin | -5.2% | -5.0% | 9.6% |
| EBITDA | -3,783,411 | -2,717,145 | 111.75M |
| Free Cash Flow | — | — | 68.75M |
| Rev Growth | +32.3% | +32.3% | +12.5% |
| Debt/Equity | 2.71 | 2.71 | 0.14 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $291.34 | +1.08% | 81.4 | 513.86B |
| AMGN | Amgen Inc | $461.10 | +0.18% | 28.5 | 249.09B |
| GILD | Gilead Sciences Inc | $168.18 | +0.36% | — | 212.04B |
| VRTX | Vertex Pharmaceuticals Inc | $546.92 | +0.81% | 30.6 | 134.77B |
| REGN | Regeneron Pharmaceuticals | $908.12 | +0.58% | 19.5 | 84.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $157.53 | +0.56% | 28.8 | 23.28B |